Pathway of cisplatin resistance in cervical cancer (IMAGE)

Korea University College of Medicine

Pathway of cisplatin resistance in cervical cancer

Caption

The study reveals that the transcription factor NANOG activates the transient receptor potential vanilloid 1 (TRPV1)—causing neuropathic pain. TRPV1 further stimulates the EGFR signaling pathway, thus leading to cisplatin resistance

Credit

Tae Woo Kim from Korea University Medicine

Usage Restrictions

Cannot be reused without permission

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.